Skip to main content
Infertility Drugs Market by Product and Geography - Forecast and Analysis 2020-2024

Infertility Drugs Market by Product and Geography - Forecast and Analysis 2020-2024

Published: May 2021 120 Pages SKU: IRTNTR41375

Market Overview at a Glance

$1.03 B
Market Opportunity
4.82%
CAGR
YoY growth 2019-2020(%)

The infertility drugs market share is expected to increase by USD 1.03 billion from 2019 to 2024, and the market’s growth momentum will accelerate at a CAGR of 4.82%.

This infertility drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers infertility drugs market segmentations by product (hormone-based therapy and others) and geography (North America, Europe, APAC, and South America). The infertility drugs market report also offers information on several market vendors, including AbbVie Inc., Allergan Plc, Bayer AG, Ferring Pharmaceuticals AS, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi among others.

What will the Infertility Drugs Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Infertility Drugs Market Size for the Forecast Period and Other Important Statistics

 

Infertility Drugs Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The growing lifestyle diseases is notably driving the infertility drugs market growth, although factors such as rising inclination toward other modes of treatment for infertility may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the infertility drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Infertility Drugs Market Driver

The rising trend of late parenthood is a key driving factor impacting the global infertility drugs market growth. Increased age of parenthood is one of the major factors leading to the infertility problem in the present generation. In fact, it has severely affected European countries and some Asian countries such as Japan. This growing trend of late motherhood is against the natural range of fertile years for women, which significantly brightens the prospects for the global infertility drugs market. Factors such as the growing use of various contraceptive technologies, increasing focus on higher education and career, and urbanization have led to the rising median age of first pregnancy, leading to falling fertility rates. Globally, more women are working than ever before, which has also increased the average age of conceiving a child. Such factors are creating more complications and often lead to infertility.

Key Infertility Drugs Market Trend

Raising awareness regarding infertility in couples is a key trend impacting the global infertility drugs market growth. There is growing awareness about sexual health, such as fertility issues across the globe. This is expected to act as a positive trend in the infertility treatment industry. Different government and non-government organizations across the globe are supporting the couples to come forward and discuss their problems and seek professional help to tackle their issues. For instance, the International Fertility Alliance (IFA) is on a mission to spread awareness about fertility issues and provide support to people with fertility-related issues. Additionally, the National Fertility Association founded the National Infertility Awareness Week, which focuses on providing the right information and answering queries about infertility.

Key Infertility Drugs Market Challenge

The rising inclination toward other modes of treatment for infertility is a key challenge negatively impacting the global infertility drugs market growth. Rising preference for other modes of treatment such as assisted reproductive technology (ART) is posing tough competition for the infertility drugs market. In developed countries, couples having problems conceiving children are inclining toward ART. IVF is the most adopted form of ART treatment. Some of the other forms of treatment for infertility are listed below. Artificial insemination/Intrauterine insemination (IUI) involves direct injection of sperm into the uterus via a thin, flexible catheter. Couples that face low sperm count in the male partner opt for such treatments.

This infertility drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2020-2024.

Parent Market Analysis

Technavio categorizes the global Infertility drugs market is a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the infertility drugs market during the forecast period.

Who are the Major Infertility Drugs Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • AbbVie Inc.
  • Allergan Plc
  • Bayer AG
  • Ferring Pharmaceuticals AS
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi

 

This statistical study of the infertility drugs market encompasses successful business strategies deployed by the key vendors. The infertility drugs market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Bayer AG - The company offers infertility drug by brand name Fostine.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The infertility drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Infertility Drugs Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the infertility drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Infertility Drugs Market?

For more insights on the market share of various regions Request for a FREE sample now!

36% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for the infertility drugs market in North America. Market growth in this region will be faster than the growth of the South American market.

An increase in infertility risk factors, among which sexually transmitted diseases (STDs), endometriosis, polycystic ovary syndrome (PCOS), poor diet, age, and diabetes are the major risk factors that will facilitate the infertility drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Product Segments in the Infertility Drugs Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The infertility drugs market share growth by the hormone-based therapy segment will be significant during the forecast period. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the infertility drugs market size and actionable market insights on post COVID-19 impact on each segment.

 

Infertility Drugs Market Scope

Report Coverage

Details

Page number

120

Base year

2019

Forecast period

2020-2024

Growth momentum & CAGR

Accelerate at a CAGR of 4.82%

Market growth 2020-2024

$ 1.03 billion

Market structure

Fragmented

YoY growth (%)

4.67

Regional analysis

North America, Europe, APAC, and South America

Performing market contribution

North America at 36%

Key consumer countries

US, UK, Canada, China, and Germany

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

AbbVie Inc., Allergan Plc, Bayer AG, Ferring Pharmaceuticals AS, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Infertility Drugs Market Report?

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will drive infertility drugs market growth during the next five years
  • Precise estimation of the infertility drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the infertility drugs industry across North America, Europe, APAC, and South America
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of infertility drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Five forces analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Product

    • Market segments
    • Comparison by Product
    • Hormone-based therapy - Market size and forecast 2020-2025
    • Others - Market size and forecast 2020-2025
    • Market opportunity by Product

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2020-2025
      • Europe - Market size and forecast 2020-2025
      • Asia - Market size and forecast 2020-2025
      • ROW - Market size and forecast 2020-2025
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Overview
      • Landscape disruption

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Abbott Laboratories
      • AbbVie Inc.
      • Bayer AG
      • Ferring Pharmaceuticals AS
      • GlaxoSmithKline Plc
      • Merck and Co. Inc.
      • Merck KGaA
      • Novartis AG
      • Pfizer Inc.
      • Sanofi SA

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Methodology

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      INFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases

      DATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts

      REPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape

      Interested in this report?

      Get your sample now to see our research methodology and insights!

      Download Now

      Frequently Asked Questions

      Infertility Drugs market growth will increase by $ 1.03 bn during 2020-2024 .

      The Infertility Drugs market is expected to grow at a CAGR of 4.82% during 2020-2024 .

      Infertility Drugs market is segmented by Product( hormone-based therapy, others) Geographic( North America, Europe, APAC, South America)

      AbbVie Inc., Allergan Plc, Bayer AG, Ferring Pharmaceuticals AS, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi are a few of the key vendors in the Infertility Drugs market.

      North America will register the highest growth rate of 36% among the other regions. Therefore, the Infertility Drugs market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

      US, UK, Canada, China, Germany

      • Growing lifestyle diseasesA sedentary lifestyle is one of the major reasons causing chronic conditions such as diabetes is the driving factor this market.
      • obesity is the driving factor this market.
      • and high blood pressure in the modern generation. Lacking physical activity and a rising sedentary lifestyle are directly expected to affect the health condition and may further become a major cause of infertility.Growing lifestyle diseases such as diabetes is the driving factor this market.
      • obesity is the driving factor this market.
      • and high blood pressureLifestyle diseases such as obesity is the driving factor this market.
      • diabetes is the driving factor this market.
      • and high blood pressure are some of the high potential factors leading to infertility. There has been a continuous rising in these chronic disease cases is the driving factor this market.
      • and some of them is the driving factor this market.
      • such as diabetes is the driving factor this market.
      • have turned into an epidemic leading to huge concern for healthcare professionals across the globe.DiabetesDiabetes comes along with an increased risk of developing a number of serious health issues. Constant high blood glucose can lead to severe health conditions and affect the body severely and may affect the healthy sex life of both males and females.Diabetes is turning to be one of the most serious health concerns for people across the world. In 2019 is the driving factor this market.
      • it was estimated that around 450-500 million adults had diabetes globally. Also is the driving factor this market.
      • around 1.45 million people die due to diabetes each year globally. In 2019 is the driving factor this market.
      • more than 50% of global patients with diabetes lived in APAC. However is the driving factor this market.
      • Africa is expected to witness the highest growth in the number of new cases is the driving factor this market.
      • mainly due to the lack of awareness and treatment facilities in the region. China is the driving factor this market.
      • India is the driving factor this market.
      • and the US have the largest number of patients with diabetes in the present scenario.Effect of diabetes on female fertilityStudies have shown that it is difficult for a woman with high glucose levels to get pregnant is the driving factor this market.
      • as it prevents the implantation of the embryo in the uterus. This results in miscarriage even before the female realizes her pregnancy. It has been found that diabetes increases the chances of miscarriage to about 45%. Even though the implantation occurs is the driving factor this market.
      • the complication stays throughout the pregnancy. Effect of diabetes on male fertilityHigh glucose level even plays a key role in causing infertility in men. A large number of diabetic men experience retrograde ejaculation is the driving factor this market.
      • a condition in which the semen stays back in the bladder is the driving factor this market.
      • thus making the movement of sperm almost impossible to reach women's reproductive organs. The production of nuclear DNA-damaged sperm cells is another major concern associated with diabetes.Globally is the driving factor this market.
      • about half of the patients with diabetes are undiagnosed is the driving factor this market.
      • which suggests that the actual number may be higher than the estimated. There is also a rising prevalence rate of diabetes in the younger population is the driving factor this market.
      • specifically those lying in the reproductive age group of 18-45 years is the driving factor this market.
      • which is the driving factor this market.
      • in turn is the driving factor this market.
      • leads to higher cases of infertility and will demand a higher volume of infertility drugs. ObesityObesity is another major risk factor that increases the chances of infertility. Rising cases of obesity are expected to bring a higher number of infertility cases and hence would act as a major factor leading to the growth of the global infertility drugs market. As per the data provided by NIH is the driving factor this market.
      • a male population with obesity in the reproductive age has almost tripled in the past three decades. Many pieces of evidence have proved the fact that male obesity has a negative impact on the sexual potential of males. It not only degrades sperm quality but also alters the molecular and physical structure of germ cells present in the testes and final mature sperm. Obesity also has a negative effect on females in the reproductive age; being obese can highly affect the chances of conceiving and delivering a healthy baby. Obesity in females can lead to hormonal imbalance and problems related to ovulation. Rising obesity cases will directly boost the demand for infertility drugs. Studies have shown that obesity cases have almost doubled from 1980 data and are still growing. Obesity itself leads to complications of infertility; in addition to this is the driving factor this market.
      • other conditions associated with obesity is the driving factor this market.
      • such as diabetes is the driving factor this market.
      • will further lead to higher infertility cases and will is the driving factor this market.
      • in turn is the driving factor this market.
      • lead to the higher growth of the global infertility drugs market. is the driving factor this market.

      The Infertility Drugs market vendors should focus on grabbing business opportunities from the hormone-based therapy segment as it accounted for the largest market share in the base year.